Cargando…

Prognostic Models Incorporating RAS Mutation to Predict Survival in Patients with Colorectal Liver Metastases: A Narrative Review

Recurrence and survival vary widely among patients who undergo curative-intent resection of colorectal liver metastases (CRLM). Prognostic models provide estimated probabilities of these outcomes and allow the effects of multiple potentially interacting variables to be adjusted and assessed simultan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Geoffrey Yuet Mun, Diakos, Connie, Molloy, Mark P., Hugh, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264993/ https://www.ncbi.nlm.nih.gov/pubmed/35804994 http://dx.doi.org/10.3390/cancers14133223

Ejemplares similares

Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022)

Recurrence patterns predict survival after resection of colorectal liver metastases
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

Surgical Management of Colorectal Liver Metastases: Prognostic Indicators and the Impact of RAS Mutation Status
por: Wei, Steven H., et al.
Publicado: (2015)

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020)

Genomic and prognostic heterogeneity among RAS/BRAF (V600E)/TP53 co‐mutated resectable colorectal liver metastases
por: Berg, Kaja C. G., et al.
Publicado: (2021)

The Presence of Mutations in the K-RAS Gene Does Not Affect Survival after Resection of Pulmonary Metastases from Colorectal Cancer
por: Zabaleta, Jon, et al.
Publicado: (2014)

Embryologic Origin of the Primary Tumor and RAS Status Predict Survival after Resection of Colorectal Liver Metastases
por: Alexandrescu, Sorin Tiberiu, et al.
Publicado: (2022)

Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver Metastases
por: Granata, Vincenza, et al.
Publicado: (2021)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
por: Díez-Alonso, Manuel, et al.
Publicado: (2021)

Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases
por: Rhaiem, Rami, et al.
Publicado: (2022)

Fast simultaneous detection of K-RAS mutations in colorectal cancer
por: Chang, Ya-Sian, et al.
Publicado: (2009)

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
por: Schirripa, M, et al.
Publicado: (2015)

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
por: Vincenzi, Bruno, et al.
Publicado: (2015)

Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
por: Dolatkhah, Roya, et al.
Publicado: (2021)

Survival time and prognostic factors of patients with initial noncurative colorectal liver metastases
por: Liu, Qizhi, et al.
Publicado: (2017)

BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies
por: Wang, Pei-Pei, et al.
Publicado: (2022)

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival
por: Akhan, Okan, et al.
Publicado: (2023)

Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)
por: Dijkstra, Madelon, et al.
Publicado: (2021)

The Prognostic Significance of Lymphatics in Colorectal Liver Metastases
por: Muralidharan, Vijayaragavan, et al.
Publicado: (2014)

The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients
por: Jácome, Alexandre A., et al.
Publicado: (2020)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Composite Score: prognostic tool to predict survival in patients undergoing surgery for colorectal liver metastases
por: Frühling, Petter, et al.
Publicado: (2021)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

Identification of prognostic inflammatory factors in colorectal liver metastases
por: Hamilton, Trevor D, et al.
Publicado: (2014)

Strategies to tackle RAS-mutated metastatic colorectal cancer
por: Patelli, G., et al.
Publicado: (2021)

The impact of RAS mutation on the treatment strategy of colorectal cancer
por: Pirvu, Edvina Elena, et al.
Publicado: (2023)

Effect of Time to Surgery of Colorectal Liver Metastases on Survival
por: Chen, Emerson Y., et al.
Publicado: (2020)

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
por: Chan, Joseph C. Y., et al.
Publicado: (2017)

Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer
por: Chan, Joseph Chung Yan, et al.
Publicado: (2020)

RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases
por: Bhullar, Dilraj, et al.
Publicado: (2022)

Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer
por: Sasaki, Yusuke, et al.
Publicado: (2016)

Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases
por: Kulik, Ulf, et al.
Publicado: (2018)

Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases
por: Brown, Kai M., et al.
Publicado: (2021)

Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021)

Is Laterality Prognostic in Resected KRAS-Mutated Colorectal Liver Metastases? A Systematic Review and Meta-Analysis
por: Belias, Michail, et al.
Publicado: (2022)

Ras oncogene mutations and survival in patients with lung cancer
por: Ferretti, G, et al.
Publicado: (2006)

Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer
por: Chan, Joseph Chung Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5dkf9if4brf6dvvmm4hi96utku